Although amorphous solid dispersions (ASDs) successfully increase bioavailability, they can result in high tablet masses. This paper describes work to reduce the tablet mass of an ASD prepared from a low-Tg, rapidly crystallizing compound. Two polymers were strategically combined to prepare a high-drug-loading ASD tablet with a 40% lower tablet mass. The tablet had similar physical stability and in vitro performance as the benchmark and exhibited excellent downstream manufacturability. To learn more, please see our publication.
Latest content